Method of treating endothelial injury
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 28, 2010
Grant Date -
May 29, 2008
app pub date -
Jun 29, 2007
filing date -
Sep 11, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully